Pressroom: Press Releases

2013

Unprecedented Cancer Alliance Announced

Memorial Sloan Kettering Cancer Center today launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare, a multi-hospital health care system in Connecticut, was selected as a pioneering member of the newly formed Memorial Sloan Kettering Cancer Alliance.

September 17, 2013
Researchers Uncover Genetic Cause of Childhood Leukemia

For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan Kettering Cancer Center, St. Jude Children’s Research Hospital, University of Washington, and other institutions.

September 8, 2013
Memorial Sloan Kettering Announces New Leadership in Thoracic Surgery and Oncology

Memorial Sloan Kettering Cancer Center has announced the appointment of David R. Jones as Chief of the Thoracic Service in the Department of Surgery, and Charles M. Rudin as Chief of the Thoracic Oncology Service, Division of Solid Tumor Oncology, in the Department of Medicine.

September 5, 2013
MRI Right Before or After Surgery Does Not Benefit Women with Early Breast Cancer

A Memorial Sloan Kettering Cancer Center study shows that the use of MRI before or immediately after surgery in women with DCIS was not associated with reduced local recurrence or contralateral breast cancer rates.

September 4, 2013
Memorial Sloan Kettering Cancer Center Unveils New Pressroom and Broadcast Studio

Memorial Sloan Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features as well as the availability of an on-site broadcast studio.

August 27, 2013
New Preferred Standard of Care for Advanced Kidney Cancer Patients

Patients with advanced kidney cancer can now take advantage of a new treatment option that has far fewer troubling side effects – this, according to a large, international trial led by Memorial Sloan Kettering Cancer Center investigators.

August 21, 2013
Study Suggests Pattern in Lung Cancer Pathology May Predict Cancer Recurrence after Surgery

A new study by thoracic surgeons and pathologists at Memorial Sloan Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence.

August 7, 2013
Most Popular Ovarian Cancer Cell Lines Do Not Resemble Ovarian Cancer

Researchers from Memorial Sloan Kettering Cancer Center recently discovered that the most frequently used cancer cell lines in ovarian cancer research are not suitable models of ovarian cancer.

July 12, 2013
Combination of Drugs Produces Dramatic Tumor Responses in Advanced Melanoma Patients

The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published in The New England Journal of Medicine and presented at the 49th Annual Meeting of the American Society of Clinical Oncology.

June 2, 2013
New Therapy Shown To Improve Progression-Free Survival and Shrink Tumors in Rare Cancer for the First Time

The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan Kettering Cancer Center research presented at the 49th annual meeting of the American Society of Clinical Oncology.

June 1, 2013
Foundation Medicine and Memorial Sloan Kettering Cancer Center Announce Partnership to Advance Patient Care in Hematologic Cancers

Foundation Medicine and Memorial Sloan Kettering Cancer Center today announced a partnership that brings together clinical, genomic and computational expertise to advance patient care in hematologic cancers.

May 2, 2013
Large Genomic Study Identifies Endometrial Cancer Subtypes, Treatment Opportunities

Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas Research Network.

May 1, 2013
New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells

Scientists from Memorial Sloan Kettering Cancer Center and Eureka Therapeutics have collaborated to create the new human monoclonal antibody, which targets a protein associated with many types of cancer and is of great interest to cancer researchers.

March 13, 2013
Memorial Sloan Kettering Appoints Avice Meehan as Vice President of Communications and Chief Communications Officer

In this new expanded role, Avice Meehan will streamline communications across the Center and lead both Memorial Sloan Kettering’s Public Affairs and Marketing endeavors.

March 12, 2013
Memorial Sloan Kettering Announces New Appointments

Memorial Sloan Kettering Cancer Center announces the appointments of medical oncologist Anas Younes, surgical pathologist David S. Kimstra, surgeon Julio Garcia-Aguilar, and radiologist Wolfgang Weber.

March 5, 2013
Drug Shown to Reverse Radioiodine Resistance in Some Advanced Thyroid Cancers

The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan Kettering Cancer Center.

February 13, 2013
Westchester Medical Center Opens New Outpatient Oncology Center in Partnership with Memorial Sloan Kettering

Westchester Medical Center today announced the opening of its new 5,300-square-foot outpatient Infusion Center, ushering in a new partnership with Memorial Sloan Kettering Cancer Center, whose staff will provide outpatient cancer care and infusion services.

February 13, 2013
IBM Watson Hard At Work: New Breakthroughs Transform Quality Care for Patients

IBM, WellPoint, Inc., and Memorial Sloan Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence-based medicine.

February 8, 2013
New Position Created to Streamline, Accelerate, and Expand Clinical Research at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center has announced the appointment of medical oncologist Paul Sabbatini to the new position of Deputy Physician-in-Chief for Clinical Research.

January 17, 2013

2012

David M. Rubenstein Gives $10 Million to Launch Pancreatic Cancer Research Center at Memorial Sloan Kettering

A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC). The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein.

December 7, 2012
Syndicate content